ArticleBMC geriatrics2025
Personalised, GIS-based counselling to promote habitual walking in mobility-limited and chronically ill older adults: protocol of the MOBITEC-Routes randomised controlled trial.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perceived importance of walking among hospitalized patients with stroke: a thematic analysis.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundPhysical activity is a cornerstone of health for older adults. Recent evidence underscores that even regular light activity, such as routine walking, offers substantial health benefits. Traditional approaches to promoting walking often overlook the importance of the local neighbourhood environment and the wide range of abilities and preferences of older adults. A personalised walking intervention - emphasizing personal preferences and local facilitators by employing Geographic information System (GIS)-based methods for communication and goal setting - might help to overcome problems of low long-term adherence to walking interventions. The MOBITEC-Routes trial aims to assess the effects of personalised, GIS-based walking promotion - versus general information on determinants of health - for mobility-limited and chronically ill older adults on walking (primary outcome) immediately after the 15-week intervention period (primary endpoint) and after another 8 months of follow-up (secondary endpoint).
methodsThis prospective, two-arm, single centre randomised controlled trial targets sedentary, mobility-limited, chronically ill, and community-living older adults aged 65 + (target N = 130). Outcomes are assessed after 15 weeks of intervention and after an additional 8 months of follow-up. The experimental intervention offers personalised promotion of habitual walking, delivered by an exercise professional in face-to-face and telephone sessions. Opportunities to increase leisure as well as utilitarian walking are identified by using interactive digital maps, personalised walking routes are co-created by the exercise professional and the participant, and a personalised activity plan is developed. Behaviour change strategies are employed. The control group receives general information on determinants of health. Outcomes include walking (average steps per day; primary outcome), time spent lying, sitting, standing and stepping, physical function, life-space mobility, health-related quality of life, fall-related self-efficacy, active aging, as well as constructs of the Health Action Process Approach (HAPA) model (secondary outcomes). Effects will be analysed by analysis of covariance (ANCOVA; primary analysis intention-to-treat, complemented by per-protocol). DISCUSSION: By incorporating personal preferences and the neighbourhood environment, this intervention aims to promote walking as a sustainable and meaningful part of everyday life for mobility-limited and chronically ill older adults. If the personalised GIS-based approach is successful, it could be seamlessly integrated into preventive healthcare strategies.
trial registrationISRCTN17473086 (Registration date 22/11/2024).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.